Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael A Feuerstein

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Biomed Research International|March 8, 2018
Advances in Localized Prostate Cancer ManagementDavid B Samadi, Michael A Feuerstein, Seyed Behzad Jazayeri, et al.
The Journal of Pediatrics|February 4, 2005
Chronic immune thrombocytopenic purpura in children: assessment of rituximab treatmentJulie Wang, Joseph M Wiley, Ruth Luddy, et al.
Current Urology|October 12, 2019
Comparison of Adjuvant Chemotherapy for Upper Tract versus Lower Tract Urothelial Carcinoma: A Systematic Review and Meta-AnalysisSeyed B Jazayeri, Jennifer S Liu, Brittany Weissman, et al.
BJU International|November 11, 2014
Patterns of surveillance imaging after nephrectomy in the Medicare populationMichael A Feuerstein, Coral L Atoria, Laura C Pinheiro, et al.
Urologic Oncology|May 10, 2015
Quality of life and symptom assessment in randomized clinical trials of bladder cancer: A systematic reviewMichael A Feuerstein, Marc Jacobs, Alfonso Piciocchi, et al.
British Journal of Haematology|April 3, 2004
The efficacy and safety of B-cell depletion with anti-CD20 monoclonal antibody in adults with chronic immune thrombocytopenic purpuraNichola Cooper, Roberto Stasi, Susanna Cunningham-Rundles, et al.
European Urology Focus|July 30, 2017
Validation of a Postoperative Nomogram Predicting Recurrence in Patients with Conventional Clear Cell Renal Cell CarcinomaByron H Lee, Andrew Feifer, Michael A Feuerstein, et al.
The Journal of Urology|December 20, 2014
Long-term survival rates after resection for locally advanced kidney cancer: Memorial Sloan Kettering Cancer Center 1989 to 2012 experienceWassim M Bazzi, Daniel D Sjoberg, Michael A Feuerstein, et al.
Molecular Cancer|April 28, 2010
Hedgehog/Gli supports androgen signaling in androgen deprived and androgen independent prostate cancer cellsMengqian Chen, Michael A Feuerstein, Elina Levina, et al.
World Journal of Urology|October 30, 2015
Low yield of surveillance imaging after surgery for T1 kidney cancerMichael A Feuerstein, John E Musser, Matthew Kent, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Biomed Research International|March 8, 2018
Advances in Localized Prostate Cancer ManagementDavid B Samadi, Michael A Feuerstein, Seyed Behzad Jazayeri, et al.
The Journal of Pediatrics|February 4, 2005
Chronic immune thrombocytopenic purpura in children: assessment of rituximab treatmentJulie Wang, Joseph M Wiley, Ruth Luddy, et al.
Current Urology|October 12, 2019
Comparison of Adjuvant Chemotherapy for Upper Tract versus Lower Tract Urothelial Carcinoma: A Systematic Review and Meta-AnalysisSeyed B Jazayeri, Jennifer S Liu, Brittany Weissman, et al.
BJU International|November 11, 2014
Patterns of surveillance imaging after nephrectomy in the Medicare populationMichael A Feuerstein, Coral L Atoria, Laura C Pinheiro, et al.
Urologic Oncology|May 10, 2015
Quality of life and symptom assessment in randomized clinical trials of bladder cancer: A systematic reviewMichael A Feuerstein, Marc Jacobs, Alfonso Piciocchi, et al.
British Journal of Haematology|April 3, 2004
The efficacy and safety of B-cell depletion with anti-CD20 monoclonal antibody in adults with chronic immune thrombocytopenic purpuraNichola Cooper, Roberto Stasi, Susanna Cunningham-Rundles, et al.
European Urology Focus|July 30, 2017
Validation of a Postoperative Nomogram Predicting Recurrence in Patients with Conventional Clear Cell Renal Cell CarcinomaByron H Lee, Andrew Feifer, Michael A Feuerstein, et al.
The Journal of Urology|December 20, 2014
Long-term survival rates after resection for locally advanced kidney cancer: Memorial Sloan Kettering Cancer Center 1989 to 2012 experienceWassim M Bazzi, Daniel D Sjoberg, Michael A Feuerstein, et al.
Molecular Cancer|April 28, 2010
Hedgehog/Gli supports androgen signaling in androgen deprived and androgen independent prostate cancer cellsMengqian Chen, Michael A Feuerstein, Elina Levina, et al.
World Journal of Urology|October 30, 2015
Low yield of surveillance imaging after surgery for T1 kidney cancerMichael A Feuerstein, John E Musser, Matthew Kent, et al.
Pageof 3